Basic Information
Ambrx Biopharma is a clinical-stage biologics company focused on discovering and developing a new class of Engineered Precision Biologics (EPB). Our proprietary Expanded Genetic Code technology platform enables us to incorporate synthetic amino acids (SAAs) into proteins within living cells in a site-specific manner.
Ambrx Biopharma, Inc.
SanDiego,California,United States of America
101~500 people
January 01, 2003
bd@ambrx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios